Background {#Sec1}
==========

There is strong evidence that adherence to physical activity guidelines is associated with health benefits and reduced mortality in both healthy and chronic disease populations \[[@CR1],[@CR2]\]. There is no specific evidence that physical activity is beneficial in bronchiectasis; however it is strongly related to mortality and lung health in other respiratory conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis \[[@CR3]-[@CR5]\]. Promoting physical activity has been proposed as a key component of care in chronic respiratory disease \[[@CR2],[@CR3],[@CR6],[@CR7]\]. International recommendations for the whole population promote a minimum of 150 minutes of at least moderate physical activity per week (accumulated in at least 10-minute bouts) and a restriction on extended periods of sedentary behaviour for promoting and maintaining health \[[@CR1]\]. The impact of bronchiectasis on sedentary behaviour and physical activity is unknown. It is important to explore this to identify the need for physical activity interventions and how to tailor interventions to this patient population.

Objective assessment of sedentary behaviour and physical activity using activity monitors has been recommended in preference to questionnaires \[[@CR7]-[@CR9]\]. In this study, we chose to use the ActiGraph activity monitor as it is one of the most studied activity monitors with demonstrated reliability and validity in respiratory disease populations \[[@CR10],[@CR11]\]. The ActiGraph activity monitor measures many different physical activity dimensions but currently there is limited research to inform clinicians on which of these variables are most useful. Van Remoortel and colleagues have proposed that time spent in different physical activity intensities, energy expenditure and step counts should all be considered to provide a comprehensive assessment \[[@CR12]\]. The ActiGraph activity monitor also measures time spent in sedentary behaviours such as lying and sitting. Previous research has highlighted how sedentary behaviour has an important role on patients' clinical progression \[[@CR13]\].

A range of clinical characteristics (disease severity, exercise capacity, health-related quality-of-life (HRQoL) and symptoms) have been shown to impact on sedentary behaviour and physical activity in other respiratory conditions \[[@CR13]-[@CR16]\]. However, their impact in bronchiectasis is unknown.

Additionally psychological and behavioural factors may also have an impact on sedentary behaviour and physical activity. An adaption of the transtheoretical model (TTM) of behaviour change can be used as a framework to identify why patients with bronchiectasis engage in physical activity or not, and when and how individuals are likely to change their physical activity behaviour \[[@CR17],[@CR18]\]. The TTM constructs include the stages of change, self-efficacy, decisional balance and both cognitive and behavioural processes of change (more details included in Table [1](#Tab1){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}). The TTM assumes that behaviour change is a dynamic process rather than an all-or-nothing phenomenon \[[@CR19]\]. However, specific data in patients with bronchiectasis using the TTM is not yet available \[[@CR18]\]. Understanding the links between physical activity and sedentary behaviour, and clinical and psychological characteristics will potentially inform the development of future physical activity interventions.Table 1**Description of each component of the transtheoretical model (TTM)TTM construct** **\[** [@CR18] **\]Description** **\[** [@CR18] **\]Stage of change**Pre-contemplationNo intention to engage in regular physical activityContemplationIntend to engage in regular physical activity in next 6 monthsPreparationImmediate intentions and commitment to engage in regular physical activityActionInitiated engagement in regular physical activity in last 6 monthsMaintenanceMaintained engagement of regular physical activity for longer than 6 months**Self-efficacy**Personal confidence towards physical activity commitment when: Tired/In a bad mood/Do not have time/On vacation/It is raining or snowing/Having respiratory symptoms\***Decisional balance**ProsPerceived benefits of engaging in regular physical activityConsPerceived barriers to engaging in regular physical activity**Cognitive processes of change**Increasing knowledgeFinding information on the benefits of physical activity and the current recommendations for physical activityBeing aware of riskConcern for the risks of being physically inactiveCaring about consequencesRealising social and environmental benefits that physical activity hasComprehending benefitsAssessing physical activity status and the values related to physical activityIncreasing healthy opportunitiesAwareness, availability and acceptance by the individual of physical activity in the society**Behavioural processes of change**Substituting alternativesSubstituting inactive options for active optionsEnlisting social supportSeeking out social support to increase and maintain physical activityRewarding oneselfProviding rewards for being more activeCommitting oneselfSetting goals and making commitments for physical activityReminding oneselfControlling factors that have a negative effect on physical activity to prevent relapse and using stimuli to increase physical activity level\*Question on 'having respiratory symptoms' was added to the original five questions.

The overall aim of this research was to explore sedentary behaviour and physical activity and correlates of these behaviours in patients with bronchiectasis. Specific objectives of this research were to explore patterns of physical activity in patients with bronchiectasis and determine if patients meet the current physical activity guidelines; and to examine the relationship between physical activity levels of patients with bronchiectasis and clinical characteristics (disease severity, exercise capacity, HRQoL and other symptoms of their disease) and constructs of the TTM (stages of change, self-efficacy, decisional balance and processes of change).

The research hypothesis was that patients with bronchiectasis would have high levels of sedentary behaviour and low levels of physical activity and these would be related to clinical characteristics and constructs of the TTM. More specifically, it was hypothesised that lower sedentary behaviour and higher levels of physical activity would be related to greater exercise capacity, greater lung function, better HRQoL and higher self-efficacy, perceiving more benefits of physical activity and using more processes of change.

Methods {#Sec2}
=======

Participant selection {#Sec3}
---------------------

Due to the exploratory nature of the study, a sample of 63 patients was feasible based on constraints of time (one-year time period) and availability of patients. Consecutive patients attending respiratory clinics at the three selected hospital sites were screened for eligibility. Inclusion criteria were: aged ≥18 years, diagnosis of bronchiectasis confirmed by high-resolution CT/CT, ≤10 pack-year smoking history, clinically stable (no pulmonary exacerbation \[more details in Additional file [1](#MOESM1){ref-type="media"}\] and no significant change in symptoms or medication in the last four weeks) and sputum bacteriology completed over the past three months. Exclusion criteria were: current severe haemoptysis, pregnancy or any other concomitant condition that would prevent participation. Study recruitment occurred over 12 months and patients were recruited across all seasons. The study was approved by Northern Ireland Research Ethics Committees (Ethics Approval Reference: 12/NI/0044) and research departments of all participating hospitals. Written informed consent was obtained from all study patients.

Study design {#Sec4}
------------

This was a cross-sectional study using quantitative methodology (Figure [1](#Fig1){ref-type="fig"}). Patients attended Visit 1 where age and gender were recorded and an assessment of body mass index (BMI) and spirometry was conducted. The ActiGraph was attached and worn for seven consecutive days following Visit 1. Eight days later, patients attended Visit 2 where they returned the ActiGraph and activity log and completed study questionnaires, spirometry, a blood test for C-reactive protein, and the Modified Shuttle Test (MST) \[[@CR20]\].Figure 1Study flow diagram showing patient enrolment, allocation and analysis. Abbreviations: QOL-B - Quality of Life Questionnaire-Bronchiectasis; LCQ - Leicester Cough Questionnaire; Transtheoretical model (TTM) questionnaires - Marcus's Self-Efficacy Questionnaire, Marcus's Decisional Balance Questionnaire, Marcus's Processes of Change Questionnaire; MST - Modified Shuttle Test.

Clinical measurements {#Sec5}
---------------------

Height and weight were measured in light clothing and without shoes using SECA digital scales and stadiometer. Spirometry was assessed using MicroLab spirometer ML3500 and classified according to American Thoracic Society/European Respiratory Society Guidelines \[[@CR21]\]. Disease severity was calculated using the Bronchiectasis Severity Index (BSI) to identify patients at risk of exacerbations, hospitalisations and mortality \[[@CR22]\] (see Additional file [1](#MOESM1){ref-type="media"}).

Physical activity was measured using the ActiGraph GT3X+ accelerometer (ActiGraph, Pensacola, Florida). Patients wore the ActiGraph during all waking hours for seven consecutive days following Visit 1. The ActiGraph was worn on an elastic belt and patients were instructed to position the ActiGraph on the anterior axillary line of the hip on their dominant side. They were advised to remove the ActiGraph before sleeping and prior to water-based activities. Patients recorded any non-wear periods in a daily activity log. The ActiGraph was initialised using the manufacturer's software (ActiLife version 6.8.0) to record movement in counts per minute summed over 15-second epochs. On Visit 1, patients were offered daily, alternate-day or once-weekly reminders to wear the ActiGraph. Each patient's ActiGraph data was considered valid if there were ≥10 hours of wear-time per day for ≥5 days, to include a Saturday or Sunday \[[@CR23],[@CR24]\]. Using ActiLife software, wear-time validation was applied using established parameters which allowed for a 2-minute interval of non-zero counts with an up/downstream 30 minutes of consecutive zero counts window \[[@CR25]\]. Patient-completed activity logs were cross-checked to explore non-wear periods. Details of sedentary behaviour and physical activity dimensions are included in Additional file [1](#MOESM1){ref-type="media"}.

Study questionnaires were administered and completed during Visit 2. The questionnaires included: Quality of Life Questionnaire-Bronchiectasis (QOL-B) \[[@CR26]\], Leicester Cough Questionnaire (LCQ) \[[@CR27]\], Stages of Change Questionnaire \[[@CR28]\], Marcus's Self-Efficacy Questionnaire (with additional disease-specific question) \[[@CR29]\], Marcus's Decisional Balance Questionnaire \[[@CR30]\] and Marcus's Processes of Change Questionnaire \[[@CR31]\]. Questionnaires were completed in a standardised order and were cross-checked by researchers to ensure no missing data (see Additional file [1](#MOESM1){ref-type="media"}).

Exercise capacity was measured using the MST, a progressive 15-stage exercise field test which is based on a standardised protocol \[[@CR20]\]. The MST was performed twice with ≥20 minute rest between tests. The greatest distance completed in either MST was used for analysis. The MST has been shown to have good reliability and validity \[[@CR32]\].

Statistical analysis {#Sec6}
--------------------

Descriptive statistics were used to summarise demographic and clinical characteristics and physical activity intensity categories.

Multiple linear regression analysis using forward selection based on likelihood ratio statistics was completed with sedentary behaviour and physical activity dimensions as the dependent variables. Dependent variables included daily sedentary behaviour time and different physical activity dimensions (see Additional file [1](#MOESM1){ref-type="media"}). Independent variables entered into the model included: BSI score, age, gender, BMI, FEV~1~% predicted, MST, LCQ domains, QOL-B domains except QOL-B Treatment Burden (this response is not scored for every patient) and constructs of the TTM (Marcus's Self-Efficacy average score, Marcus's Decisional Balance 'pros' and 'cons' scores, Marcus's Processes of Change cognitive and behavioural average scores). As this was an exploratory study, no correction was made for multiplicity. The significance levels are therefore descriptive rather than inferential.

Between-group analysis using independent sample t-tests were used to explore differences for selected variables. All statistical analyses were performed using SPSS version 20.0.0 (IBM). Unless otherwise stated, summary data are reported as mean(SD) and statistical significance as p \< 0.05.

Results {#Sec7}
=======

Sixty-three patients completed the study visits. Eight datasets were not valid, leaving fifty-five datasets for analysis (Figure [1](#Fig1){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). BSI scores categorised patients' disease severity as mild (49%), moderate (33%) and severe (18%) \[[@CR9]\]. In general, bronchiectasis impacted on patients' HRQoL across most QOL-B domains. The QOL-B indicated that patients perceived a high Treatment Burden and a low Health Perception. They had good Emotional Functioning and were not largely affected by Respiratory Symptoms. The LCQ indicated that chronic cough impacted on HRQoL, with highest perceived impact on the Physical domain (lowest LCQ domain score). C-reactive protein at study entry was 4(4)mg/L (Table [2](#Tab2){ref-type="table"}).Table 2**Demographic and clinical characteristics of patients with bronchiectasis (n = 55)**Age (years)63 (10)Gender (male / female)22 \[40\]/33 \[60\]BMI (kg/m^2^)27 (4)FEV~1~ (litres)2 (1)FEV~1~ (% predicted)76 (21)FVC (litres)3 (1)FVC (% predicted)94 (19)FEF%38 (22)FEF~25--75~ (litres)1 (0.8)C-Reactive Protein (mg/L)4 (4)**Disease severity (%)\***Mild27 \[49\]Moderate18 \[33\]Severe10 \[18\]**Smoking history**Never (%)46 \[84\]Ex-smoker (%)9 \[16\]**Antibiotic courses**Number of oral antibiotic courses within last year3 (2)Number of IV antibiotic courses within last year0-3 (range)**QOL-B (0--100, 0 worst to 100 best)**Physical Functioning59 (31)Role Functioning56 (12)Vitality63 (13)Emotional Functioning83 (17)Social Functioning60 (23)Treatment Burden (n = 41)39 (13)Health Perception45 (16)Respiratory Symptoms70 (19)**LCQ (1--7, 1 worst to 7 best)**Physical4.96 (1.43)Psychological5.27 (1.52)Social5.50 (1.29)LCQ total score (range from 3 to 21)15.72 (3.99)Results are Mean (SD) or Frequency \[%\].*Abbreviations:* *BMI* Body Mass Index, *FEF* Forced Expiratory Flow, *FEF* ~*25--75*~ Forced Expiratory Flow between 25% to 75%, *FEV* ~*1*~ *%* predicted Forced Expiratory Volume in one-second percentage predicted, *FVC* Forced Vital Capacity (% predicted), *LCQ* Leicester Cough Questionnaire, *QOL-B* Quality of Life in Bronchiectasis.\*Disease severity based on Bronchiectasis Severity Index \[[@CR22]\].

Sedentary behaviour and physical activity levels {#Sec8}
------------------------------------------------

Average daily time spent in sedentary behaviour was 634(77)mins, light-lifestyle physical activity was 207(63)mins and moderate-vigorous physical activity (MVPA) was 25(20)mins. Only 11% of patients met the recommended physical activity guidelines of ≥150mins of at least moderate physical activity per week \[[@CR1]\]. Patients completed 6001(2780) daily steps and 232(75)mins of daily total physical activity. Using the graduated step-based physical activity index, 42% of patients were classified as inactive, 29% as low active and 29% as somewhat active and above \[[@CR33]\]. Mean distance covered in the MST was 511(273)metres (Table [3](#Tab3){ref-type="table"}).Table 3**Sedentary behaviour (ActiGraph), physical activity (ActiGraph) and exercise capacity (MST) for patients with bronchiectasis (n = 55)Average times in sedentary behaviour and different physical activity intensities:**Sedentary behaviour time (mins/day)634 (77)Light-lifestyle physical activity time (mins/day)207 (63)Total MVPA time (mins/day)25 (20)MVPA~10+~ time (mins/week)44 (64)MVPA~10+~ time (mins/day)6 (9)Activity energy expenditure (kcals/day)309 (183)Daily step counts6001 (2780)Total physical activity (mins/day)232 (75)Physical activity category Inactive \[%\]23 \[42\]Physical activity category Low active \[%\]16 \[29\]Physical activity category Somewhat active and above \[%\]16 \[29\]**Exercise capacity:**MST (metres)511 (273)Results are Mean (SD) or Frequency \[%\].ActiGraph physical activity categories: Inactive (\<5000 steps per day), low active (5000--7499 steps per day) and somewhat active and above (≥7500 steps per day).*Abbreviations:* *kcals/day* kilocalories per day, *MVPA* moderate-vigorous physical activity, *MVPA* ~*10+*~ MVPA accumulated in ≥10-minute bouts, *mins/day* minutes per day, *mins/week* minutes per week, *MST* Modified Shuttle Test.

Correlates of sedentary behaviour and physical activity {#Sec9}
-------------------------------------------------------

Table [4](#Tab4){ref-type="table"} shows variables for inclusion in the regression analysis with a p-value below 5%. The correlates selected in this study explained 10-38% of the variance in sedentary behaviour and physical activity. Forced expiratory volume in one-second percentage predicted (FEV~1~% predicted) and disease severity (BSI score) were not correlates of sedentary behaviour or any physical activity variable. The MST was not a correlate of sedentary behaviour time. For sedentary behaviour time, decisional balance 'pros' score was a correlate variable; with those who were more sedentary observing less benefits of physical activity. For physical activity variables, the MST was the most strongly related correlate variable. For MVPA accumulated in ≥10-minute bouts, QOL-B Social Functioning was also a correlate variable; with those who completed more MVPA in ≥10-minute bouts having higher Social Functioning. For activity energy expenditure, BMI and QOL-B Respiratory Symptoms were also correlate variables; with those who had greater activity energy expenditure having a higher BMI and worse Respiratory Symptoms (Table [4](#Tab4){ref-type="table"}).Table 4**Correlate variables for sedentary behaviour and physical activity for patients with bronchiectasis (n = 55)Dependent variableCorrelate variableUnstandardised coefficients B(SE)R** ^**2**^ **adjustedp value**Daily sedentary behaviour timeMarcus's Decisional Balance 'pros' score−28.964 (10.609)0.1070.009Daily light-lifestyle PA timeNo correlates\-\-\-\-\-\-\-\--Daily total MVPA timeMST0.037 (0.008)0.2580.001Daily MVPA~10+~ timeQOL-B Social Functioning0.162 (0.050)0.1490.002MST0.009 (0.004)0.2070.032Daily AEEMST0.351 (0.077)0.2690.001BMI12.769 (4.767)0.3450.010QOL-B Respiratory Symptoms−2.215 (1.074)0.3840.044Daily step countsMST5.813 (1.127)0.3220.001Daily total PA timeMST0.088 (0.035)0.0870.016*Abbreviations:* *AEE* activity energy expenditure, *BMI* Body Mass Index, *MST* Modified Shuttle Test, *MVPA* moderate-vigorous physical activity, *MVPA* ~*10+*~ MVPA accumulated in ≥10-minute bouts, *PA* physical activity, *QOL-B* Quality of Life-Bronchiectasis.

Patients with moderate/severe disease (BSI score: ≥5) spent significantly less time in daily total MVPA time, had lower activity energy expenditure, fewer daily step counts and achieved lower MST distance than those with mild disease (BSI score: ≤4) (Table [5](#Tab5){ref-type="table"}).Table 5**Differences across disease severity for sedentary behavior, physical activity and exercise capacity for patients with bronchiectasisDisease severity: Mild BSI score ≤ 4(n = 27)Disease severity: Moderate/severe BSI score ≥ 5(n = 28)**Sedentary behavior time (mins/day)632 (64)635 (88)Light-lifestyle physical activity time (mins/day)210 (55)204 (71)Total MVPA time (mins/day)32 (19)18 (18)^a^MVPA~10+~ time (mins/day)8 (10)5 (8)Activity energy expenditure (kcals/day)390 (173)231 (159)^b^Daily step counts6898 (2783)5137 (2532)^c^Total physical activity time (mins/day)242 (65)221 (84)MST (metres)593 (323)432 (199)^d^Results are Mean (SD).Note: Disease severity expressed as Bronchiectasis Severity Index score \[[@CR22]\].*Abbreviations:* *kcals/day* kilocalories per day, *MVPA* moderate-vigorous physical activity, *MVPA* ~*10+*~ MVPA accumulated in bouts ≥10 minutes, *mins/day* minutes per day, *MST* Modified Shuttle Test.^a^Daily Total MVPA: significant difference between groups (p = 0.005).^b^Daily Activity Energy Expenditure: significant difference between groups (p = 0.001).^c^Daily Step Counts: significant difference between groups (p = 0.017).^d^MST: significant difference between groups (p = 0.030).

Fifty-five percent of patients reported that they were in an 'inactive' stage of change (pre-contemplation, contemplation or preparation stages) while 45% reported themselves to be in an 'active' stage of change (action or maintenance stages) in relation to their participation in physical activity (Table [6](#Tab6){ref-type="table"}). Patients reported reduced confidence when faced with situations that could impact on their ability to participate in physical activity; being most confident that they could be physically active when on holiday and least confident when they had respiratory symptoms. They also perceived both benefits ('pros') and barriers ('cons') to physical activity. Decisional balance scores (perceived benefits minus perceived barriers) showed patients perceived marginally more benefits. Overall, patients used cognitive and behavioural strategies equally in their physical activity behaviour (Table [6](#Tab6){ref-type="table"}).Table 6**Stages of change scores and TTM questionnaire scores for patients with bronchiectasisStage of change:**Stage 1 pre-contemplation \[%\]4 \[7\]Stage 2 contemplation \[%\]6 \[11\]Stage 3 preparation \[%\]20 \[36\]Stage 4 action \[%\]3 \[6\]Stage 5 maintenance \[%\]22 \[40\]**Marcus's self-efficacy:(1--5, 1 not at all confident to 5 very confident in being active)**When tired2.27 (0.95)When in a bad mood2.96 (1.19)When do not have time2.53 (1.07)When on vacation3.35 (1.22)When raining/snowing2.33 (1.25)When having respiratory symptoms1.65 (0.97)Mean of all 6 self-efficacy domains2.52 (0.48)**Marcus's decisional balance:(scores \> 0 indicate perceptions of more benefits than barriers in being active, scores \< 0 indicate perceptions of more barriers than benefits in being active)**Pros (1--5, higher scores perceive more benefits in being active)3.53 (0.93)Cons (1--5, higher scores perceive more barriers in being active)2.62 (0.75)Overall decisional balance score (difference between pros minus cons)0.91 (1.01)**Marcus's processes of change:(1--5, higher scores indicate greater usage of strategies to become more active)***Cognitive Processes*Increasing knowledge2.49 (0.81)Being aware of risks2.35 (1.01)Caring about consequences to others2.52 (1.04)Comprehending benefits3.16 (1.01)Increasing healthy opportunities2.34 (0.94)Cognitive processes mean2.57 (0.78)*Behavioural Processes*Substituting alternatives2.99 (0.98)Enlisting social support2.40 (0.93)Rewarding oneself2.44 (0.94)Committing oneself3.07 (0.95)Reminding oneself1.92 (0.72)Behavioural processes mean2.56 (0.70)Results are Mean (SD) or Frequency \[%\].

Discussion {#Sec10}
==========

This is the first study to report patterns of sedentary behaviour and physical activity in bronchiectasis. The results demonstrate a more sedentary and less active profile for people with bronchiectasis compared to the recommended guidelines for physical activity. These findings are important as recent research has suggested a link with inactivity and decreased survival, poorer HRQoL and increased healthcare utilisation in chronic disease populations such as COPD and diabetes \[[@CR3],[@CR4],[@CR33]-[@CR36]\]. Furthermore, there is increasing evidence that a high level of sedentary behaviour is associated with adverse health outcomes in chronic disease populations \[[@CR36]-[@CR38]\].

To contextualise these study findings, we have compared our bronchiectasis data to similar ActiGraph data available for English, Swedish and USA healthy populations \[[@CR39]-[@CR43]\] and to another respiratory population \[[@CR16]\] (see Additional file [2](#MOESM2){ref-type="media"}). Albeit the healthy data sets are more heterogeneous in terms of age and ethnicity, some important contrasts emerge. Patients with bronchiectasis appear to have similar levels of sedentary behaviour and physical activity compared to the English healthy population \[[@CR42]\]; both populations fall well below recommended guidelines for physical activity \[[@CR1]\]. Patients with bronchiectasis appear to be more sedentary and less physically active compared to healthy Swedish and USA populations \[[@CR39]-[@CR41],[@CR43]\]. USA population-based ActiGraph data is available in COPD. Patients with bronchiectasis appear to have a similar sedentary behaviour and physical activity profile; despite being younger in age \[[@CR16]\]. When designing physical activity interventions in bronchiectasis, researchers may need to consider the impact of patients' baseline sedentary behaviour and physical activity levels as well as current and new symptoms.

We hypothesised that lower levels of sedentary behaviour and higher levels of physical activity would be related to greater exercise capacity, greater lung function, better HRQoL and higher self-efficacy, perceiving more benefits of physical activity and using more processes of change. FEV~1~% predicted and BSI score did not correlate with sedentary behaviour time or physical activity variables highlighting that neither of these assessments should be used clinically as indicators of either sedentary behaviour or physical activity. Whilst MST did not predict sedentary behavior, MST consistently correlated with physical activity variables. This association between physical activity and exercise capacity has previously been demonstrated in bronchiectasis \[[@CR44]\] and highlights the potential importance of exercise interventions, such as pulmonary rehabilitation, to improve physical activity levels in patients with bronchiectasis. Based on positive findings from five key pulmonary rehabilitation studies in bronchiectasis \[[@CR45]-[@CR49]\], recent British Thoracic Society Guidelines for Pulmonary Rehabilitation recommend referral to pulmonary rehabilitation for patients with bronchiectasis who have breathlessness affecting their activities of daily living \[[@CR6]\]. The most recent of these studies by Lee et al. \[[@CR49]\] recruited patients with a very similar demographic profile into a quality randomised controlled trial of eight weeks of pulmonary rehabilitation versus control and demonstrated that pulmonary rehabilitation was associated with short-term improvement in exercise capacity, dyspnoea and fatigue; although these improvements were not sustained at 12-month follow-up. The positive effects of pulmonary rehabilitation on exercise capacity across chronic respiratory conditions have been shown to consistently diminish over time \[[@CR6]\]. With limited access to maintenance programmes, alternative strategies to reduce sedentary behaviour and/or increase and sustain physical activity may be important. Unfortunately, as with earlier studies, physical activity was not included as an outcome measure and further research is needed to establish whether changes in exercise capacity translate to changes in physical activity or whether physical activity needs to be specifically targeted in bronchiectasis.

There were important differences in the predictors of sedentary behaviour versus physical activity. In fact, decisional balance 'pros' score was the only correlate of sedentary behaviour suggesting that sedentary behaviour in bronchiectasis could be influenced more by psychological factors rather than physiological factors. The data shows that it is important to assess patients' sedentary behaviour and physical activity levels directly. We also propose that it may be important to focus on behaviour change techniques and other behavioural strategies such as motivational interviewing \[[@CR50]\] rather than exercise training alone if targeting a decrease in sedentary behaviour as well as improved physical activity levels in patients with bronchiectasis.

Although activity energy expenditure was estimated using equations developed for healthy populations, an interesting relationship emerged with QOL-B Respiratory Symptoms scores. Patients with higher activity energy expenditure appeared to have worse respiratory symptoms. Patients with chronic respiratory disease potentially have an increased oxygen cost of breathing compared with healthy populations due to respiratory dynamics \[[@CR51]\].

In COPD, recent research suggests that higher physical activity levels are associated with higher self-efficacy and less depressive symptoms in patients with COPD \[[@CR52]\]. We have shown that patients with bronchiectasis perceived a range of barriers to participation in physical activity, with those who were more sedentary perceiving more barriers. They employed a range of cognitive and behavioural strategies to modify their physical activity behaviour. The most employed strategies were: realising benefits of being physically active, making commitments to be physically active and replacing inactive choices with active choices. Future intervention studies could focus on optimising frequently used strategies as well as considering the value of less commonly used strategies to support patients in altering their physical activity behaviour.

A major strength of this study was the use of validated instruments to assess physical activity, exercise capacity and HRQoL in a bronchiectasis population. This facilitated rigorous exploration of the correlates of sedentary behaviour and physical activity in bronchiectasis. One limitation may be that due to the exploratory nature of this study, no sample size calculation was performed. Nevertheless, this exploration has provided a useful insight into understanding correlates of sedentary behaviour and physical activity in bronchiectasis.

Conclusions {#Sec11}
===========

In summary, many patients with bronchiectasis demonstrated a largely inactive lifestyle and few met the recommended physical activity guidelines. FEV~1~% predicted and disease severity were not correlates of sedentary behaviour or physical activity. Exercise capacity was the strongest correlate of physical activity, and dimensions of the QOL-B were also important. Despite patients understanding the benefits of physical activity, many reported low levels of self-confidence in physical activity in certain situations, particularly when experiencing respiratory symptoms. This study highlights the need for physical activity interventions in bronchiectasis and provides information to tailor interventions to this patient population.

Additional files {#Sec12}
================

Additional file 1:**Additional details of methods and materials used in the study.**Additional file 2:**Comparing sedentary behaviour and physical activity in patients with bronchiectasis to healthy and COPD populations.**
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